Skip to main content.

Valley fever basics

Fellowship Story Showcase

Valley fever basics

Why are people still dying from valley fever and tens of thousands getting sick?  Misdiagnosis. A lack of public awareness. And a long history of inaction by government agencies. In this series, we will explore the startling rise of cases, the science of studying the disease, the high costs to patients and taxpayers, the weak federal and private interest in funding treatments and vaccines, and the public health response.

Valley Fever - 101
Saturday, September 8, 2012

By Yesenia Amaro


What is valley fever?

Valley fever, also known as coccidioidomycosis, is a disease caused by a fungus called coccidioides immitis found in the soil primarily in certain parts of the Southwestern United States, Mexico and Central and South America. A person can become infected by inhaling the spores of the fungus. The infection starts in the lungs, but can spread to other organs in the body and the bones. 

What are the symptoms?

Fever, a persistent cough that won’t go away, night sweats, weight loss, and different kinds of rashes. Once a person is infected with the fungus, it does not leave the body.

How is it diagnosed?

Most commonly through a blood test. It can also be diagnosed through a biopsy of where the infection is located.

How can it be treated?

The first step is correctly diagnosing the disease. Clinicians should find out whether it has spread and identify the patient’s risk factors for it causing severe illness. If the infection is confined to the lungs and a patient has no other risk factors, current guidelines call only for monitoring the patient to see if the fever goes away. If the infection has spread and patients are at high risk of complications, clinicians often turn to antifungal drugs, such as fluconazole, sold as Diflucan, and surgery.

How common is valley fever?

Researchers estimate that there are 150,000 people stricken with valley fever every year nationally, but the vast majority of cases are not misdiagnosed as something else or never treated. Those cases that are diagnosed have been rising dramatically, by more than 12-fold since 1995. It kills about 100 people every year.

How can people prevent becoming infected?

One of the challenges in preventing the disease is a lack of clear guidelines. In known high-risk areas, people working outdoors are encouraged to wear a mask and construction crews are encouraged to keep dust down by wetting the area. Studies in mice have shown that, in principal, a vaccine would work, but funding for developing a vaccine has been scarce.

 Who is at most risk?

Blacks, Filipinos, people with chronic health conditions, such as diabetes or cancer, recent organ transplant recipients and pregnant women are at most risk for developing severe complications from the disease.

Sources: Michael Mac Lean, health officer for the Kings County Department of Public Health; Dr. James McCarty, head of the pediatric infectious disease unit at Children’s Hospital Central California in Madera; The Environmental Health and Safety Division at California State University, Fullerton.

 

About This Series

This project results from an innovative reporting venture – the Center for Health Journalism Collaborative – which currently involves the Bakersfield Californian, Radio Bilingüe in Fresno, Valley Public Radio in Fresno and Bakersfield, Vida en el Valle in Fresno, Hanford Sentinel, the Voice of OC in Santa Ana, the Arizona Daily Star in Tucson, La Estrella de Tucsón and the Center for Health Journalism. The collaborative is an initiative of the Center for Health Journalism at the University of Southern California’s Annenberg School for Communication and Journalism.

RELATED STORIES THIS WEEK

Accurate valley fever counts elude health officials

“Valley fever is almost certainly underreported, due to physicians and the public not being familiar with the disease,” said one infectious disease specialist. Reliable estimates of valley fever cases are still lacking.

CDC technology advances promise better valley fever detection

New sensors in development at the CDC could provide a breakthrough in valley fever detection and prevention throughout the Southwestern United States.

New valley fever skin test shows promise, but obstacles remain

A new skin test called Spherusol can detect whether a person has developed immunity to valley fever. But despite its promise, the test still isn’t in wide use.

FORECASTING AN EPIDEMIC: Does weather hold the key to predicting valley fever outbreaks?

As recently as August, Calif. health officials predicted the number of valley fever cases this year would go down. Now it’s shaping up to be one of the worst years on record.

Public pushes for new thinking in valley fever research

Advocates of valley fever research have complained that the disease does not affect enough people to garner attention and funding; local doctors often misdiagnosed it; most data about the disease dates back decades; and the public has little knowledge of the disease and its impact.

Valley Fever Research Day Aims To Connect With Community

Community members are invited to attend Valley Fever Research Day Saturday at the UCSF Fresno Center for Medical Education and Research. The event is an opportunity for researchers to connect with community members who have been impacted by the fungal disease.

Federal, local officials hopeful for 'new era' in valley fever

Many questions about valley fever remained unanswered Tuesday as public health officials, physicians and politicians finished a two-day symposium on the disease, but many were hopeful that the summit will be a turning point.

Agencies to Launch Randomized Controlled Trial for Valley Fever

Directors of the National Institutes of Health and U.S. Centers for Disease Control and Prevention tell a packed valley fever symposium they are "serious" about finding a better treatment for the disease.